Published in PLoS Med on October 01, 2006
Inferring pathway activity toward precise disease classification. PLoS Comput Biol (2008) 3.48
A decade of systems biology. Annu Rev Cell Dev Biol (2010) 2.30
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer (2009) 2.13
Assessing cancer risks of low-dose radiation. Nat Rev Cancer (2009) 1.53
Establishing trusting partnerships for successful recruitment of American Indians to clinical trials. Cancer Control (2008) 1.41
Biodosimetry on small blood volume using gene expression assay. Health Phys (2010) 1.33
Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics (2010) 1.33
Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res (2008) 1.30
Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: synchronous and differential responses. BMC Med Genomics (2008) 1.22
Functional genomics in radiation biology: a gateway to cellular systems-level studies. Radiat Environ Biophys (2007) 1.18
H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype. Br J Cancer (2010) 1.09
Pathway-based classification of cancer subtypes. Biol Direct (2012) 1.05
TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. PLoS One (2010) 1.03
Induced expression of the IER5 gene by gamma-ray irradiation and its involvement in cell cycle checkpoint control and survival. Radiat Environ Biophys (2009) 0.97
Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies. PLoS One (2012) 0.96
Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer (2008) 0.91
Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. World J Gastroenterol (2007) 0.91
Constitutive gene expression profile segregates toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat Oncol (2009) 0.89
A novel high-throughput irradiator for in vitro radiation sensitivity bioassays. Phys Med Biol (2014) 0.88
Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett (2016) 0.85
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy. Radiat Oncol (2011) 0.82
A radiation-derived gene expression signature predicts clinical outcome for breast cancer patients. Radiat Res (2009) 0.82
Identification of radiation-induced expression changes in nonimmortalized human T cells. Radiat Res (2010) 0.82
Functional Genomics and a New Era in Radiation Biology and Oncology. Bioscience (2008) 0.81
Big Data Analytics for Prostate Radiotherapy. Front Oncol (2016) 0.80
Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapy. Br J Radiol (2013) 0.80
Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol Med (2017) 0.79
Multivariate inference of pathway activity in host immunity and response to therapeutics. Nucleic Acids Res (2014) 0.79
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology. Future Oncol (2008) 0.79
Can the severity of normal tissue damage after radiation therapy be predicted? PLoS Med (2006) 0.78
Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification. Brief Bioinform (2015) 0.77
miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110. Oncotarget (2016) 0.77
Molecular and Functional Diagnostic Tools in Precision Oncology for Urological Malignancies. Indian J Surg Oncol (2016) 0.76
Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. Radiat Oncol (2011) 0.75
Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC. Front Immunol (2017) 0.75
TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. Oncotarget (2016) 0.75
Improving radiotherapy in cancer treatment: Promises and challenges. Oncotarget (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Network biology: understanding the cell's functional organization. Nat Rev Genet (2004) 36.62
Genetic analysis of genome-wide variation in human gene expression. Nature (2004) 27.28
From molecular to modular cell biology. Nature (1999) 23.51
Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet (2005) 17.75
A module map showing conditional activity of expression modules in cancer. Nat Genet (2004) 8.57
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell (2004) 8.18
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys (2002) 6.82
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. Mol Cancer Res (2002) 5.42
Microarrays and molecular research: noise discovery? Lancet (2005) 4.79
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res (2005) 3.79
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol (2001) 3.06
An array of problems. Nat Rev Drug Discov (2005) 2.55
A systematic statistical linear modeling approach to oligonucleotide array experiments. Math Biosci (2002) 2.53
Modularity and evolutionary constraint on proteins. Nat Genet (2005) 2.32
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys (2005) 2.31
Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res (2000) 2.11
Global network analysis of phenotypic effects: protein networks and toxicity modulation in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2004) 1.90
Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res (2003) 1.77
Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. Nucleic Acids Res (2004) 1.68
EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys (1995) 1.59
Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys (1996) 1.50
Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys (2002) 1.46
Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A (2004) 1.39
Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol (2003) 1.14
Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer (1992) 1.13
Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. Int J Radiat Oncol Biol Phys (2003) 1.00
Lymphocyte count and mortality risk in older persons. The Leiden 85-Plus Study. J Am Geriatr Soc (2003) 0.99
Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys (2003) 0.98
Towards genetic prediction of radiation responses: ESTRO's GENEPI project. Radiother Oncol (2003) 0.95
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet (1992) 0.93
Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat Res (1991) 0.93
Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol (2002) 0.92
Biological response to radiation therapy. Acta Oncol (2003) 0.84
Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. Radiother Oncol (2002) 0.84
Dissecting systems-wide data using mixture models: application to identify affected cellular processes. BMC Bioinformatics (2005) 0.78
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med (2004) 32.09
Clonogenic assay of cells in vitro. Nat Protoc (2006) 11.85
Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur J Immunol (2002) 2.57
A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev (2003) 2.09
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06
A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol (2003) 1.84
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. BMC Cancer (2009) 1.80
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol (2005) 1.77
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res (2007) 1.76
Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol (2006) 1.76
Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer (2007) 1.73
Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2010) 1.68
The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions. DNA Repair (Amst) (2005) 1.57
Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J (2011) 1.45
p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol (2002) 1.38
Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol (2012) 1.37
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci U S A (2011) 1.36
Developmental defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B. Mol Cell Biol (2002) 1.20
DNA double strand break quantification in skin biopsies. Radiother Oncol (2004) 1.18
PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1. J Cell Biol (2012) 1.18
Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation. Cancer Res (2005) 1.17
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation. J Neurooncol (2011) 1.17
Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines. Int J Radiat Oncol Biol Phys (2007) 1.16
Prognostic model for survival in patients with early stage cervical cancer. Cancer (2010) 1.16
Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2004) 1.13
Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.10
Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene (2003) 1.08
Microarray analysis of gene expression profiles of cardiac myocytes and fibroblasts after mechanical stress, ionising or ultraviolet radiation. BMC Genomics (2005) 1.07
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status. Blood (2009) 1.07
Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis. BMC Cancer (2010) 1.06
Bowel perforation after radiotherapy in a patient receiving sorafenib. J Clin Oncol (2008) 1.05
Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer (2013) 1.04
Comparison of RBE values of high-LET α-particles for the induction of DNA-DSBs, chromosome aberrations and cell reproductive death. Radiat Oncol (2011) 1.02
Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer (2010) 1.02
Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients. Haematologica (2007) 1.01
Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol (2007) 1.00
Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts. DNA Repair (Amst) (2008) 0.98
A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2008) 0.98
Transcription-dependent cytosine deamination is a novel mechanism in ultraviolet light-induced mutagenesis. Curr Biol (2009) 0.98
Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol (2013) 0.97
Gene transcription increases DNA damage-induced mutagenesis in mammalian stem cells. DNA Repair (Amst) (2008) 0.97
Transcription-coupled repair: impact on UV-induced mutagenesis in cultured rodent cells and mouse skin tumors. Mutat Res (2005) 0.96
Nucleotide excision repair in differentiated cells. Mutat Res (2006) 0.96
Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys (2008) 0.96
Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer (2007) 0.95
Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. Anticancer Res (2011) 0.94
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR Am J Roentgenol (2012) 0.93
Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells. Mol Cell Biol (2011) 0.93
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. Crit Rev Oncol Hematol (2008) 0.93
Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol (2007) 0.92
Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int J Radiat Oncol Biol Phys (2002) 0.91
Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary. Int J Radiat Oncol Biol Phys (2006) 0.90
Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys (2007) 0.90
Targeting the Akt-pathway to improve radiosensitivity in glioblastoma. Curr Pharm Des (2013) 0.89
Differential activity of UV-DDB in mouse keratinocytes and fibroblasts: impact on DNA repair and UV-induced skin cancer. DNA Repair (Amst) (2008) 0.89
Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression. Cancer (2008) 0.89
Deciphering the RNA landscape by RNAome sequencing. RNA Biol (2015) 0.88
A portrait of cisplatin-induced transcriptional changes in mouse embryonic stem cells reveals a dominant p53-like response. Mutat Res (2007) 0.88
Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment. Chem Res Toxicol (2014) 0.88
Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. J Urol (2006) 0.88
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system. Genes Chromosomes Cancer (2002) 0.87
Is short-course radiotherapy with high doses per fraction the appropriate regimen for metastatic spinal cord compression in colorectal cancer patients? Strahlenther Onkol (2006) 0.87
Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys (2007) 0.87
Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys (2005) 0.87
The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals. Toxicol Sci (2011) 0.86
A method to separate the rectum from the prostate during proton beam radiotherapy of prostate cancer patients. Acta Oncol (2010) 0.86
PCC and COBRA-FISH a new tool to characterize primary cervical carcinomas: to assess hall-marks and stage specificity. Cancer Lett (2009) 0.85
Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids. J Cancer Res Clin Oncol (2003) 0.85
Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol (2008) 0.85
Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis (2003) 0.85
Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer. Prostate Cancer (2012) 0.84
Validation of a score predicting post-treatment ambulatory status after radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2010) 0.84
DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients. Anticancer Res (2010) 0.84
Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration. J Cancer Res Clin Oncol (2005) 0.84
Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patients. Radiother Oncol (2008) 0.84
Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery (2011) 0.84
Do radiation oncologists tailor information to patients needs? And, if so, does it affect patients? Acta Oncol (2012) 0.84
Enhanced global genome nucleotide excision repair reduces UV carcinogenesis and nullifies strand bias in p53 mutations in Csb-/- mice. J Invest Dermatol (2010) 0.83
Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys (2006) 0.83
Spinal reirradiation after short-course RT for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2005) 0.83
Cellular-signaling pathways unveil the carcinogenic potential of chemicals. J Appl Toxicol (2013) 0.83
Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin. Oncol Rep (2007) 0.83
Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Strahlenther Onkol (2007) 0.83
Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines. Part Fibre Toxicol (2014) 0.83
Effect of single dose irradiation on human glioblastoma spheroids in vitro. Oncol Rep (2004) 0.82
Validation of existing prognostic models in patients with early-stage cervical cancer. Gynecol Oncol (2009) 0.82
Feasibility of electric property tomography of pelvic tumors at 3T. Magn Reson Med (2014) 0.81
Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair (Amst) (2012) 0.81
Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. J Radiat Res (2004) 0.81
Role of MRI in detecting involvement of the uterine internal os in uterine cervical cancer: systematic review of diagnostic test accuracy. Eur J Radiol (2013) 0.81
G0 cell cycle arrest alone is insufficient for enabling the repair of ionizing radiation-induced potentially lethal damage. Radiat Res (2008) 0.81